Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sean A. Mccarthy currently holds 1,078,922 shares of CytomX Therapeutics, Inc. (CTMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sean A. Mccarthy has been a net seller of CTMX stock. They have purchased $0 and sold $8.9M worth of shares.
Sean A. Mccarthy's most recent insider trade was on Mar 17, 2026, when they sold 118,969 shares at $6.42 per share.
Sean A. Mccarthy serves as Executive at CytomX Therapeutics, Inc. (CTMX). They have executed 108 insider transactions totaling $8.9M over their tenure at the company.
Sean A. Mccarthy holds the position of Executive at CytomX Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Sean A. Mccarthy has shown a selling trading pattern, with $0 in total purchases and $8.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sean A. Mccarthy was on Mar 17, 2026, when they sold $764.1K worth of CTMX shares. This transaction involved 118,969 shares at $6.42 per share.
Sean A. Mccarthy currently owns 1,078,922 shares of CytomX Therapeutics, Inc. (CTMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sean A. Mccarthy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sean A. Mccarthy has 108 Form 4 filings on record as an insider at CytomX Therapeutics, Inc..
Set alerts for Sean A. Mccarthy and 40,000+ other insiders.